Skip to main navigation Skip to search Skip to main content

EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation

  • Dong Hoe Koo
  • , Kyu Pyo Kim
  • , Chang Min Choi
  • , Dae Ho Lee
  • , Jae Cheol Lee
  • , Jung Shin Lee
  • , Se Jin Jang
  • , Sang We Kim
  • University of Ulsan
  • Sungkyunkwan University

Research output: Contribution to journal › Article › peer-review

23   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science